Vestcor Inc Increases Position in Addus HomeCare Co. (NASDAQ:ADUS)

Vestcor Inc boosted its holdings in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 58.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,150 shares of the company’s stock after acquiring an additional 1,524 shares during the period. Vestcor Inc’s holdings in Addus HomeCare were worth $520,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of ADUS. Quarry LP purchased a new stake in Addus HomeCare during the 3rd quarter valued at about $28,000. Smartleaf Asset Management LLC boosted its holdings in Addus HomeCare by 324.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 280 shares of the company’s stock valued at $35,000 after purchasing an additional 214 shares during the last quarter. Parkside Financial Bank & Trust boosted its holdings in Addus HomeCare by 38.6% in the 4th quarter. Parkside Financial Bank & Trust now owns 531 shares of the company’s stock valued at $67,000 after purchasing an additional 148 shares during the last quarter. KBC Group NV boosted its holdings in Addus HomeCare by 49.1% in the 4th quarter. KBC Group NV now owns 814 shares of the company’s stock valued at $102,000 after purchasing an additional 268 shares during the last quarter. Finally, Assetmark Inc. boosted its holdings in Addus HomeCare by 11.5% in the 3rd quarter. Assetmark Inc. now owns 1,169 shares of the company’s stock valued at $156,000 after purchasing an additional 121 shares during the last quarter. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Insider Buying and Selling at Addus HomeCare

In other Addus HomeCare news, CEO R Dirk Allison sold 25,000 shares of the stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $124.76, for a total value of $3,119,000.00. Following the sale, the chief executive officer now directly owns 79,397 shares of the company’s stock, valued at approximately $9,905,569.72. This represents a 23.95 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Insiders own 4.60% of the company’s stock.

Addus HomeCare Stock Down 0.6 %

Addus HomeCare stock opened at $90.28 on Monday. The firm has a market cap of $1.64 billion, a PE ratio of 20.66, a price-to-earnings-growth ratio of 1.41 and a beta of 0.97. Addus HomeCare Co. has a 52-week low of $87.88 and a 52-week high of $136.72. The company’s 50 day moving average is $115.30 and its two-hundred day moving average is $123.17.

Addus HomeCare (NASDAQ:ADUS) last released its earnings results on Monday, February 24th. The company reported $1.26 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.35 by ($0.09). The business had revenue of $297.14 million for the quarter, compared to analyst estimates of $291.04 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. On average, equities research analysts anticipate that Addus HomeCare Co. will post 4.59 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on ADUS shares. Oppenheimer boosted their target price on shares of Addus HomeCare from $145.00 to $150.00 and gave the company an “outperform” rating in a report on Friday, January 24th. Citizens Jmp upgraded shares of Addus HomeCare to a “strong-buy” rating in a report on Monday, December 16th. StockNews.com lowered shares of Addus HomeCare from a “buy” rating to a “hold” rating in a report on Wednesday, February 26th. JMP Securities assumed coverage on shares of Addus HomeCare in a report on Monday, December 16th. They issued an “outperform” rating and a $150.00 price objective on the stock. Finally, Stephens restated an “overweight” rating and issued a $142.00 price objective on shares of Addus HomeCare in a report on Wednesday, March 12th. One research analyst has rated the stock with a sell rating, one has given a hold rating, seven have issued a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $132.78.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.